Vitaherpavak

Vitagerpavac: an effective vaccine against herpes

Vitagerpavac is a vaccine developed by the Russian company Vitapharma for the prevention of herpes. Herpes is a viral disease that causes a blistering rash on the skin and mucous membranes. The virus can be transmitted through contact with infected skin or mucous membranes, as well as through sexual contact. The Vitagerpavac vaccine is designed to help prevent herpes and reduce the risk of infection.

Vitagerpavak is produced in the form of a lyophilisate, which is prepared before use by diluting with water for injection. After preparing the solution, it is administered subcutaneously. The vaccine contains an inactivated herpes virus that stimulates the body's immune system to fight infection.

Vitagerpavac is produced in Russia by Vitapharma, which specializes in the production of vaccines. The herpetic vaccine is also known under the synonyms “herpetic culture inactivated dry vaccine” and “dry herpetic vaccine”.

The effectiveness of Vitagerpavac has been confirmed in clinical studies. The vaccine showed a high degree of protection against herpes in people who received it. It also allows you to shorten the period of exacerbation of the disease and reduce the risk of transmitting the virus to other people.

The Vitagerpavac vaccine can be given to people suffering from recurrent herpes or people who are at high risk of contracting herpes. However, like any other vaccine, it may cause side effects such as mild redness and swelling at the injection site and, rarely, fever. Therefore, before using Vitagerpavac, you should consult your doctor.

In conclusion, Vitagerpavac is an effective herpes vaccine that helps prevent symptoms and reduce the risk of transmission of the virus. It is produced in Russia by Vitapharma and can be prescribed to people suffering from recurrent herpes or at high risk of infection. Although Vitagerpavac may cause side effects, they are usually mild and short-lived.